Axsome Therapeutics (AXSM) Misses Q1 EPS by 93c
Axsome Therapeutics (NASDAQ: AXSM) reported Q1 EPS of ($1.03), $0.93 worse than the analyst estimate of ($0.10).
For earnings history and earnings-related data on Axsome Therapeutics (AXSM) click here.
Axsome Therapeutics (NASDAQ: AXSM) reported Q1 EPS of ($1.03), $0.93 worse than the analyst estimate of ($0.10).
For earnings history and earnings-related data on Axsome Therapeutics (AXSM) click here.